DrugDashboards

Heparin Sodium

Heparin Sodium · HEPARIN SODIUM 10000 [USP'U]/100mL · Injection, Solution · Intravenous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1411-03 · 24 POUCH in 1 CASE / 1 POUCH in 1 POUCH / 1 BAG in 1 POUCH / 250 mL in 1 BAG · NDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for heparin sodium (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $54.61 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA018916
TE code
AP
Approval date
Jan 31, 1984
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)Nov 14, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
  • In shortage now — Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)Nov 14, 2017
    Other
    month 106 — 5× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Heparin Sodium (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationHEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 10000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hepalink USA Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hepalink USA Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.HEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Hospira, Inc.HEPARIN SODIUM 5000 [USP'U]/100mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.HEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 3, 2026
BE Pharmaceuticals Inc.HEPARIN SODIUM 2000 [USP'U]/2mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 20000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCHEPARIN SODIUM 200 [USP'U]/100mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.HEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hepalink USA Inc.HEPARIN SODIUM 20000 [USP'U]/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.HEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.HEPARIN SODIUM 5000 [USP'U]/.5mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Phlow CorporationHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 1000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceticalsHEPARIN SODIUM 5000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsHEPARIN SODIUM 10000 [USP'U]/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Heparin Sodium — NDC 51662-1411-03," retrieved September 3, 2026, https://drugdashboards.com/drug/51662141103.

Free to cite with attribution — see how the data is put together.